Skip to main content
. Author manuscript; available in PMC: 2016 May 23.
Published in final edited form as: Am J Transplant. 2009 Jun 12;9(8):1835–1845. doi: 10.1111/j.1600-6143.2009.02710.x

Figure 2. BAFF mRNA is increased in monocytes of alemtuzumab patients.

Figure 2

(A) RT-QPCR performed for eight patients at 2–4 months posttransplant and four patients 26–28 months post-transplant. (B) Correlation between BAFF mRNA levels and serum BAFF levels in the eight patients measured at the 2–4 month time point. Pearson correlation coefficients were generated to test whether an association exists between BAFF levels and monocyte BAFF mRNA levels. (C) MCF of BAFF on the monocytes of normal, BAFFmed and BAFFhigh alemtuzumab patients at early and late posttransplant time points. Statistics performed via unpaired two-tailed t-test.